Celiac Disease (CD)-Market Insights, Epidemiology and Market Forecast-2023

Publisher Name :
Date: 31-Jan-2017
No. of pages: 67
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's "Celiac Disease (CD)- Market Insights, Epidemiology and Market Forecast-2023" report provides an overview of the disease and global market size of the Celiac Disease for the 6MM (United States and EU5 countries (France, Germany, Italy, Spain and UK)). It also includes global historical and forecasted epidemiological data for the diagnosed prevalent cases of Celiac Disease from 2013-2023.

Celiac disease is a genetic autoimmune disease where the indigestion of gluten leads to damage in the small intestine. The number of ways celiac disease can affect patients, combined with a lack of training in medical schools and primary care residency programs, contributes to the poor diagnosis rate. Currently it is estimated that 80% of the celiac disease population remains undiagnosed. Prevalence in Western Europe and in the United States ranges between 1 in 250 and 1 in 133. It is higher in relatives of people with celiac disease. Women are affected more commonly than men, but there is no age predilection. DelveInsight forecasts predict that the total prevalent cases of Celiac Disease is expected to accentuate up to 4.69 Million by 2023 at a Compound Annual Growth Rate (CAGR) of 0.46% from 2013-2023 while the diagnosed prevalent population of Celiac Disease in the 6MM shall grow at a CAGR of 0.15% for the forecast period (2013-2023).

There is no targeted therapy approved for celiac disease. The current standard of care treatment involves a gluten free diet (GFD). Steroids and immunosuppressants are used to reduce symptoms in severe cases. Owing to the expected launch of Larazotide Acetate (Innovate Pharmaceuticals) in 2021 followed by the launch of Latiglutenase (ImmunogenX/Abbvie) in 2023, shall lead to a hike in the otherwise stable, worldwide market size of celiac disease. DelveInsight estimates suggest that the global market size is expected to grow at a CAGR of 19% from 2013-2023.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by Publisher team of industry experts.

Scope

- Report covers the disease overview including pathophysiology, symptoms, diagnosis, disease management, and current treatment options.

- It focuses on the detailed historical and forecasted number of total prevalent cases as well as diagnosed prevalent cases of Celiac Disease for 6MM from 2013-2023.

- The Report also includes historical and forecasted Market size of Celiac Disease for 6MM from 2013 to 2023.

- It provides the information of available marketed therapies, including off-label biologics, patent and exclusivity details.

- The report also focuses on the details of pipeline drugs in the pivotal stage of development including their SWOT Analysis and expected launch date, which shall help to predict the impact of those drugs on the market size in the near future.

Celiac Disease (CD)-Market Insights, Epidemiology and Market Forecast-2023

Table of Contents

Report Introduction
Celiac Disease Market Size Overview at a Glance
Worldwide Market Size of Celiac Disease in 2013
Worldwide Market Size of Celiac Disease in 2023
Celiac Disease Overview
Celiac Disease Types
Non-Responsive or Refractory CD
Etiology
Symptoms
Diagnosis
Disease Management
Disease Treatment
Treatment of Celiac Disease
Treatment of Non-Responsive or Refractory Celiac Disease (RCD)
Current Unmet Medical Needs
Epidemiology Parameters
Iceberg Model
Genetic Predisposition
Epidemiology &Patient Population
United States
Diagnosed Prevalent Cases of Celiac Disease in United States (2013-2023)
EU5 Countries
France
Diagnosed Prevalent Cases of Celiac Disease in France (2013-2023)
Germany
Diagnosed Prevalent Cases of Celiac Disease in Germany (2013-2023)
Italy
Diagnosed Prevalent Cases of Celiac Disease in Italy (2013-2023)
Spain
Diagnosed Prevalent Cases of Celiac Disease in Spain (2013-2023)
United Kingdom
Diagnosed Prevalent Cases of Celiac Disease in United Kingdom (2013-2023)
Emerging Phase III Therapies
Larazotide acetate
Product Description
Regulatory Milestones
Clinical Development
Clinical Pipeline Activity
Clinical Trial by Phase
SWOT Analysis
Latiglutenase
Product Description
Regulatory Milestones
Clinical Development
Clinical Pipeline Activity
Clinical Trial by Phase
SWOT Analysis
AMG 714
Product Description
Regulatory Milestones
Clinical Development
Clinical Pipeline Activity
Clinical Trial by Phase
SWOT Analysis
Celiac Disease Market Size
Global Market Size of Celiac Disease (2013-2023)
Region-Wise Market size of Celiac Disease (2013-2023)
United States
Total Market Size of Celiac Disease (2013-2023)
European Five Countries
Italy
Total Market Size of Celiac Disease (2013-2023)
Germany
Total Market Size of Celiac Disease (2013-2023)
France
Total Market Size of Celiac Disease(2013-2023)
United Kingdom
Total Market Size of Celiac Disease (2013-2023)
Spain
Total Market Size of Celiac Disease (2013-2023)
Japan- Epidemiology and Market Size
Market Drivers
Market Barriers
Appendix
Report Methodology
Consulting Services
Disclaimer
About DelveInsight

List of Tables

Table 1:Diagnosed Prevalent Cases of Celiac Disease in United States (2013-2023)
Table 2:Diagnosed Prevalent Cases of Celiac Disease in France (2013-2023)
Table 3:Diagnosed Prevalent Cases of Celiac Disease in Germany (2013-2023)
Table 4:Diagnosed Prevalent Cases of Celiac Disease in Italy (2013-2023)
Table 5:Diagnosed Prevalent Cases of Celiac Disease in Spain (2013-2023)
Table 6:Diagnosed Prevalent Cases of Celiac Disease in United Kingdom (2013-2023)
Table 7: Larazotide acetate, Clinical Trials by Zone, 2017
Table 8: Latiglutenase, Clinical Trials by Zone, 2017
Table 9: AMG 714, Clinical Trials by Zone, 2017
Table 11: Total Market size of Celiac Diseasein USD, Million(2013-2023)
Table 12: Total Market size of Celiac Disease (Region-Wise) in USD, Million(2013-2023)
Table 13: US market size of Celiac Diseasein USD, Million(2013-2023)
Table 14: Italy market size of Celiac Diseasein USD, Million(2013-2023)
Table 15: Germany market size of Celiac Disease in USD, Million(2013-2023)
Table 16: France market size of Celiac Diseasein USD, Million(2013-2023)
Table 17: United Kingdom market size of Celiac Diseasein USD, Million(2013-2023)
Table 18:Spain market size of Celiac Disease in USD, Million(2013-2023)

List of Figures

Figure 1: Diagnosed Prevalent Cases of Celiac Disease in United States (2013-2023)
Figure 2: Diagnosed Prevalent Cases of Celiac Disease in France (2013-2023)
Figure 3: Diagnosed Prevalent Cases of Celiac Disease in Germany (2013-2023)
Figure 4: Diagnosed Prevalent Cases of Celiac Disease in Italy (2013-2023)
Figure 5: Diagnosed Prevalent Cases of Celiac Disease in Spain (2013-2023)
Figure 6: Diagnosed Prevalent Cases of Celiac Disease in United Kingdom (2013-2023)
Figure 7: Larazotide acetate, Clinical Trials by Zone (%), 2017
Figure 8: Latiglutenase, Clinical Trials by Zone (%), 2017
Figure 9: AMG 714, Clinical Trials by Zone (%), 2017
Figure 11: Total Market Size of Celiac Disease in USD, Million(2013-2023)
Figure 11: Region-Wise Market size of Celiac Disease in USD, Million(2013-2023)
Figure 13: US Market Size of Celiac Disease in USD, Million(2013-2023)
Figure 14: Italy market size of Celiac Disease in USD, Million(2013-2023)
Figure 15: Germany market size of Celiac Disease in USD, Million (2013-2023)
Figure 16: France market size of Celiac Disease in USD, Million(2013-2023)
Figure 17: United Kingdom market size of Celiac Disease in USD, Million(2013-2023)
Figure 18: Spain market size of Celiac Disease in USD, Million(2013-2023)
  • Global Chronic Idiopathic Constipation Drug Market Forecast 2017-2025
    Published: 24-Sep-2017        Price: US 2500 Onwards        Pages: 122
    Key Findings Global Chronic Idiopathic Constipation drug market is estimated to grow at a CAGR of 8.37% during the forecast period of 2017-2025. The important drivers propelling the market growth are the modern dietary habits, rising elderly population and the improved and efficient drugs in the pipeline. Linaclotide is the major type of drug popular in this market. Market Insight The CIC drug market is segmented based on drug types and also on the basis of prescript......
  • Global Opioid Induced Constipation Drug Market Forecast 2017-2025
    Published: 24-Sep-2017        Price: US 2500 Onwards        Pages: 125
    Key Findings Global Opioid-Induced Constipation (OIC) drug market is estimated to grow at a CAGR of 7.08% during the forecast period of 2017 - 2025. The major drivers responsible for the market growth include the growing use of opioid, rising geriatric population, growing opioid prescription in North America and Europe, detection of safety threats and the easy availability of improved and effective OIC drugs. Some of the commonly prescribed opioids are Percocet, Vicodin, and codeine.......
  • Asia-Pacific Chronic Idiopathic Constipation Drug Market Forecast 2017-2025
    Published: 24-Sep-2017        Price: US 1250 Onwards        Pages: 67
    Key Findings The Asia-Pacific chronic idiopathic constipation drug market is predicted to expand at a CAGR of 10.30% over the forecast period of 2017-2025. The revenue generated by the market is expected to rise from $683 million in 2016 and reach $1615 million by 2025. MARKET INSIGHTS The Asian CIC drug market can be segmented by the type of drug and by the type of prescription. The drug lubiprostone is dominating the drug segment closely followed by the drug linaclotide. B......
  • Europe Chronic Idiopathic Constipation Drug Market Forecast 2017-2025
    Published: 24-Sep-2017        Price: US 1250 Onwards        Pages: 65
    Key Findings The Europe chronic idiopathic constipation drug market is estimated to grow at a CAGR of 8.80% during the forecast years of 2017-2025.The market value is estimated to increase from $1283 million in 2016 and reach $2721 million by 2025. Market Insights The market has plenty of growth opportunities owing to the unmet needs of CIC drugs in certain countries. The market can be segmented into two types on the basis of the type of prescriptions and the type of drugs. ......
  • North America Chronic Idiopathic Constipation Drug Market Forecast 2017-2025
    Published: 24-Sep-2017        Price: US 1250 Onwards        Pages: 68
    Key Findings The North America Chronic Idiopathic Constipation Drug Market is expected to grow at a CAGR of 6.92%. The market value is expected to rise from $1822 million in 2016 to $3358 million by 2025. The changing modern dietary habits, chances of cancer or other systematic disease leading to CIC and the growing increasing elderly population are some of the factors driving the market. Market Insights The North America chronic idiopathic constipation drug market i......
  • Asia Pacific Opioid Induced Constipation (OIC) Drug Market Forecast 2017-2025
    Published: 24-Sep-2017        Price: US 1250 Onwards        Pages: 65
    Key Findings The Asia-Pacific Opioid Constipation Drug market is estimated to grow at a CAGR of 8.99% during the forecast period of 2017-2025. The market worth is expected to increase from $797 million in 2016 and reach $1708 million by 2025. The ease of the availability of new and improved drugs and the growing geriatric population are currently driving the Asian Market. Market Insights The Asian market can be classified on the basis of drug type and prescription type. The ......
  • Europe Opioid Induced Constipation (OIC) Drug Market Forecast 2017-2025
    Published: 24-Sep-2017        Price: US 1250 Onwards        Pages: 62
    Key Findings The Europe opioid-induced constipation drug market is expected to grow at a CAGR of 7.51% during the forecast period of 2017-2025. The market value is predicted to increase from $1497million in 2016 and reach up to $2877 million by the end of 2025. Market Insights The Europe opioid constipation drug market is mainly driven by the increasing opioids prescription in the region. The market can be segmented into two criteria. First is the market by drug type that in......
  • North America Opioid Induced Constipation (OIC) Drug Market Forecast 2017-2025
    Published: 24-Sep-2017        Price: US 1250 Onwards        Pages: 65
    Key Findings The North America opioid-induced constipation drug market is expected to command the global OIC drug market during the forecast period of 2017-2025 with an expected CAGR growth of 5.65%. The revenue generated by the market is expected to increase from $2125 million in 2016 and reach $3551 million by 2025. Market Insights The North American OIC drug market is segmented on the basis of the type of prescription and the type of drug. The prescription type market is ......
  • Global Anti Peptic Ulcer Drugs Market Professional Survey Report 2017
    Published: 22-Sep-2017        Price: US 3500 Onwards        Pages: 114
    This report studies Anti Peptic Ulcer Drugs in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Eisai - Daewoong Pharmaceutical - Takeda Pharmaceutical - H......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs